CD105 as a Marker of Angiogenesis in Oral Squamous Cell Carcinoma – An Immunohistochemical Study

Contemporary Clinical Dentistry · Published 2025-04-01 · DOI 10.4103/ccd.ccd_521_24

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.4103/ccd.ccd_521_24

Abstract

Background: Oral squamous cell carcinoma (OSCC) is the most prevalent carcinoma of the head-and-neck region. Despite advanced tissue diagnosis, the survival period remains at 5 years. New molecular and cell markers are under investigation to improve survival rate. Objective: The objective of this study was to assess angiogenic activity by analyzing CD105 microvascular density (MVD) count in different histologic grades of OSCC. Subjects and Methods: Sixty samples are categorized into four groups. Immunohistochemical method with anti-CD105 was used for analyzing MVD. Results: The mean count of MVD is higher in OSCC than in normal mucosa and also significant among different histologic grades. A highly significant correlation is observed among different groups of OSCC samples. Conclusion: CD105 is a predictive marker for neoangiogenesis in OSCC.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles